RRRebeccah Riley

Rebeccah Riley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rebeccah Riley has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cardiac FGF21 acts as an endocrine suppressor of female fertility in mitochondrial cardiomyopathy

    by Eric Verdin, Olga Bielska, Wendy Jara, Prasanna Kumaar, Génesis Vega Hormazabal, Bikem Soygur, Anne Marker, Ritesh Tiwari, Navreet Raj, Indra Heckenbach, et al.

    Cardiomyopathy is clinically associated with female infertility, yet whether the failing heart directly suppresses reproduction has remained unknown. Here we identify a heart–brain endocrine axis in which pathological cardiac stress induces systemic elevation of the mitokine FGF21, which in turn suppresses the hypothalamic-pituitary-gonadal axis and inhibits fertility. In female mice with dilated cardiomyopathy caused by mitochondrial fission deficiency (Mff KO), we observe delayed puberty, anovulation, and hypogonadotropic hypogonadism due to blunted LH secretion and selective suppression of hypothalamic kisspeptin neurons. Exogenous kisspeptin administration restores ovulation despite persistent cardiac dysfunction. Integrated transcriptomics and metabolomics analyses reveal that the signal originates from a cardiac mitochondrial integrated stress response that drives de novo FGF21 expression in the heart. Cardiac-specific Mff re-expression abolishes the signal at its source, while genetic deletion of Fgf21 fully restores puberty and fertility even in the presence of ongoing cardiomyopathy. These findings demonstrate that cardiac-derived FGF21 acts as a key endocrine suppressor of the reproductive axis during heart failure, revealing an inter-organ communication pathway that links cardiac mitochondrial stress to reproductive control.

  • Author Correction: Regulation of urea cycle by reversible high-stoichiometry lysine succinylation

    by Ran Zhang, Jingqi Fang, Xueshu Xie, Chris Carrico, Jesse G. Meyer, Lei Wei, Joanna Bons, Jacob Rose, Rebeccah Riley, Ryan Kwok, et al.

  • Open Access

    Ketone ester supplementation in aged mice reduces activation of B cell subsets

    by Ariel Adkisson-Floro, Ritesh Tiwari, Mitsunori Nomura, Rebeccah R. Riley, Ryan Kwok, Durai Sellegounder, Mir M. Khalid, Herbert G. Kasler, John C. Newman, Eric Verdin

    Aging in the immune system results in increased susceptibility to infections, exacerbated autoimmunity, and reduced responsiveness to vaccines. However, there are no current established interventions for immune aging. Ketogenic diets and fasting have been researched as interventions against other aspects of aging and age-related diseases, and they work in part by increasing circulating levels of ketone bodies, which have anti-inflammatory properties and can boost T cell function. Exogenous ketones, such as ketone esters, are currently being studied as a more accessible approach to obtain the benefits of ketone bodies through direct supplementation. Here, we investigated whether ketone ester supplementation improves immune function during aging. Aged (19-month-old) C57BL/6JN mice were given a diet supplemented with the ketone ester or a control diet for 15 weeks. We found that the ketone ester diet decreased activation of B cells, especially age-associated B cells, in the spleen. In spite of this decrease in activation, mice on the ketone ester diet showed no impairment in antibody production after nitrophenyl-ovalbumin immunization. The ketone ester diet also inhibited glucose dependence and translation of age-associated B cells, likely through inhibition of mTOR signaling via ketone bodies. Our study elucidates the effect of ketone esters on B cells in the context of aging and unveils a new immunoregulatory role of ketone bodies on B cells.

  • Open Access

    CD38 Inhibition Ameliorates Age-Related Cognitive Decline via a Choroid Plexus–Cerebrospinal Fluid–Hippocampus Axis

    by Eric Verdin, Jingqi Fang, Rebeccah Riley, Kevin Schneider, Rosalba Perrone, Prasanna Kumaar, Christina King, Grant Kauwe, Andrea Roberts, Genesis Vega Hormazabal, et al.

    Age-related cognitive decline represents a major and unresolved challenge of human aging. Here, we identify the NAD⁺-consuming enzyme CD38 as a central regulator of cognitive aging acting through a choroid plexus–cerebrospinal fluid (CSF)–hippocampus axis. CD38 expression increases with age and localizes primarily to pericytes in the choroid plexus, where it depletes NAD⁺, impairs mitochondrial function, and promotes cellular senescence. Genetic ablation or pharmacological inhibition of CD38 restores NAD⁺ levels, suppresses senescence markers, and improves choroid plexus function, resulting in a rejuvenated CSF proteomic and metabolomic profile characterized by reduced inflammatory signaling and enhanced neurotrophic support. These changes propagate to the hippocampus, reversing age-related transcriptional signatures and enhancing synaptic plasticity. A novel, brain-penetrant CD38 inhibitor, NTX-748, reproduced the benefits of CD38 deficiency—elevating systemic and brain NAD⁺ levels, improving long-term potentiation, and enhancing multiple domains of cognition in aged mice. Collectively, these findings identify the choroid plexus as a metabolic gatekeeper of brain aging and establish CD38 inhibition as a promising therapeutic strategy to promote cognitive resilience and healthy brain aging.


  • Open Access

    Multiplexed Targeted Spatial Mass Spectrometry Imaging Assays to monitor lipids and NAD+ metabolites in CD38 knockout mice exhibiting improved metabolism

    by Birgit Schilling, Charles Schurman, Joanna Bons, Prasanna Kumaar, Jingji Fang, Andrea Roberts, Genesis Hormazabal, Rebeccah Riley, Nannan Tao, Eric Verdin

    Mass spectrometry imaging (MSI) is a rapidly advancing technology that provides mapping of the spatial molecular landscape of tissues for a variety of analytes. Matrix-assisted laser desorption/ionization (MALDI)-MSI is commonly employed, however, confident in situ identification and accurate quantification of analytes remain challenging. We present a novel imaging methodology combining trapped ion mobility spectrometry (TIMS)-based parallel accumulation-serial fragmentation (PASEF) with MALDI ionization for targeted imaging parallel reaction monitoring (iprm-PASEF). We investigated the spatial distribution of lipids and metabolites in liver tissues from wild-type and CD38 knockout mice (CD38 −/− ). CD38, an enzyme involved in nicotinamide adenine dinucleotide (NAD⁺) metabolism, significantly influences liver metabolic function and contributes to age-related NAD⁺ decline. Although CD38 deletion previously was linked to improved metabolic phenotypes, the underlying spatial metabolic mechanisms are poorly understood. The spatial iprm-PASEF workflow enabled confident identification and differentiation of lipid isomers at the MS2 fragment ion level and revealed increased NAD + and decreased adenosine diphosphate ribose (ADPR), a by-product of NAD + hydrolysis, in CD38 −/− livers. This approach provided confident, specific, and robust MS2-based identification and quantification of fragment ions in spatial MSI experiments. Additionally, the innovative iprm-PASEF opens unprecedented opportunities for spatial metabolomics and lipidomics, offering spatially resolved insights into molecular mechanisms.


  • Open Access

    Multiplexed Targeted iprm-PASEF Assays for MALDI Mass Spectrometry Imaging of Lipids, NAD + , and Related Metabolites in CD38 Knockout Mice

    by Charles A. Schurman, Joanna Bons, Prasanna Vadhana Ashok Kumaar, Jingqi Fang, Andrea Roberts, Genesis Vega Hormazabal, Rebeccah R. Riley, Nannan Tao, Eric Verdin, Birgit Schilling

    Mass spectrometry imaging (MSI) maps the molecular landscape of tissues; however, confident in situ identification and accurate quantification of analytes by matrix-assisted laser desorption/ionization (MALDI)-MSI remain challenging. We present a new targeted imaging methodology, imaging parallel reaction monitoring parallel accumulation-serial fragmentation (iprm-PASEF), which utilizes trapped ion mobility spectrometry (TIMS) and MALDI for assessment of metabolites and lipids on the fragment ion level in tissue. We investigated liver tissues from wild-type and CD38 knockout (CD38 -/- ) mice, as CD38 contributes to age-related nicotinamide adenine dinucleotide (NAD + ) decline and direct detection of NAD + within tissue remains challenging. The iprm-PASEF workflow enabled confident differentiation of lipid isomers, resolving phosphatidylinositols at m/z 857.52 and confirming the presence of PI 36:4(16:0/20:4) and absence of PI 36:4(14:0/22:4) at the fragment ion level. We confirmed a more than 2-fold increase in NAD + in CD38 -/- liver tissues of male and female animals (n = 3 per genotype and sex) and decreased adenosine diphosphate ribose (ADPR) through relative quantification of characteristic fragment ions, confirming alteration of NAD metabolism in these animals. This approach provided confident and specific MS2-based identification and relative quantification of fragment ions in MSI experiments, with consistent fold changes across multiple characteristic fragment ions and biological replicates.


  • Open Access

    Viral gene drive spread during herpes simplex virus 1 infection in mice

    by Marius Walter, Anoria K. Haick, Rebeccah Riley, Paola A. Massa, Daniel E. Strongin, Lindsay M. Klouser, Michelle A. Loprieno, Laurence Stensland, Tracy K. Santo, Pavitra Roychoudhury, et al.

    Gene drives are genetic modifications designed to propagate efficiently through a population. Most applications rely on homologous recombination during sexual reproduction in diploid organisms such as insects, but we recently developed a gene drive in herpesviruses that relies on co-infection of cells by wild-type and engineered viruses. Here, we report on a viral gene drive against human herpes simplex virus 1 (HSV-1) and show that it propagates efficiently in cell culture and during HSV-1 infection in mice. We describe high levels of co-infection and gene drive-mediated recombination in neuronal tissues during herpes encephalitis as the infection progresses from the site of inoculation to the peripheral and central nervous systems. In addition, we show evidence that a superinfecting gene drive virus could recombine with wild-type viruses during latent infection. These findings indicate that HSV-1 achieves high rates of co-infection and recombination during viral infection, a phenomenon that is currently underappreciated. Overall, this study shows that a viral gene drive could spread in vivo during HSV-1 infection, paving the way toward therapeutic applications.


  • Top Cited Papers
    Open Access

    Development of an epigenetic clock resistant to changes in immune cell composition

    by Alan Tomusiak, Ariel Floro, Ritesh Tiwari, Rebeccah Riley, Hiroyuki Matsui, Nicolas Andrews, Herbert G. Kasler, Eric Verdin

    Epigenetic clocks are age predictors that use machine-learning models trained on DNA CpG methylation values to predict chronological or biological age. Increases in predicted epigenetic age relative to chronological age (epigenetic age acceleration) are connected to aging-associated pathologies, and changes in epigenetic age are linked to canonical aging hallmarks. However, epigenetic clocks rely on training data from bulk tissues whose cellular composition changes with age. Here, we found that human naive CD8+ T cells, which decrease in frequency during aging, exhibit an epigenetic age 15–20 years younger than effector memory CD8+ T cells from the same individual. Importantly, homogenous naive T cells isolated from individuals of different ages show a progressive increase in epigenetic age, indicating that current epigenetic clocks measure two independent variables, aging and immune cell composition. To isolate the age-associated cell intrinsic changes, we created an epigenetic clock, the IntrinClock, that did not change among 10 immune cell types tested. IntrinClock shows a robust predicted epigenetic age increase in a model of replicative senescence in vitro and age reversal during OSKM-mediated reprogramming.


  • Regulation of urea cycle by reversible high-stoichiometry lysine succinylation

    by Ran Zhang, Jingqi Fang, Xueshu Xie, Chris Carrico, Jesse G Meyer, Lei Wei, Joanna Bons, Jacob Rose, Rebeccah Riley, Ryan Kwok, et al.

    The post-translational modification lysine succinylation is implicated in the regulation of various metabolic pathways. However, its biological relevance remains uncertain due to methodological difficulties in determining high-impact succinylation sites. Here, using stable isotope labelling and data-independent acquisition mass spectrometry, we quantified lysine succinylation stoichiometries in mouse livers. Despite the low overall stoichiometry of lysine succinylation, several high-stoichiometry sites were identified, especially upon deletion of the desuccinylase SIRT5. In particular, multiple high-stoichiometry lysine sites identified in argininosuccinate synthase (ASS1), a key enzyme in the urea cycle, are regulated by SIRT5. Mutation of the high-stoichiometry lysine in ASS1 to succinyl-mimetic glutamic acid significantly decreased its enzymatic activity. Metabolomics profiling confirms that SIRT5 deficiency decreases urea cycle activity in liver. Importantly, SIRT5 deficiency compromises ammonia tolerance, which can be reversed by the overexpression of wild-type, but not succinyl-mimetic, ASS1. Therefore, lysine succinylation is functionally important in ammonia metabolism.


  • Open Access

    Development of a novel epigenetic clock resistant to changes in immune cell composition

    by Alan Tomusiak, Ariel Floro, Ritesh Tiwari, Rebeccah Riley, Hiroyuki Matsui, Nicolas Andrews, Herbert G. Kasler, Eric Verdin

    Epigenetic clocks are age predictors that use machine-learning models trained on DNA CpG methylation values to predict chronological or biological age. Increases in predicted epigenetic age relative to chronological age (epigenetic age acceleration) are connected to aging-associated pathologies, and changes in epigenetic age are linked to canonical aging hallmarks. However, epigenetic clocks rely on training data from bulk tissues whose cellular composition changes with age. We found that human naive CD8 + T cells, which decrease during aging, exhibit an epigenetic age 15–20 years younger than effector memory CD8 + T cells from the same individual. Importantly, homogenous naive T cells isolated from individuals of different ages show a progressive increase in epigenetic age, indicating that current epigenetic clocks measure two independent variables, aging and immune cell composition. To isolate the age-associated cell intrinsic changes, we created a new clock, the IntrinClock, that did not change among 10 immune cell types tested. IntrinClock showed a robust predicted epigenetic age increase in a model of replicative senescence in vitro and age reversal during OSKM-mediated reprogramming.